Schwartz-Stem Cell Research Summit
June 9, 2005
Contact: Kay Kendall (713) 677-7736
Office of Communications
Institute of Biosciences and Technology
The Texas A&M University System Health Science Center
Web address:
IBT Scientist Will Represent A&M Health Science Center at Stem Cell Summit in Houston
Robert Schwartz, Ph.D.
, associate director of the Institute of Biosciences and Technology (IBT), is representing The Texas A&M University System Health Science Center at a gathering of national and international specialists that will discuss stem cell research. Dr. Schwartz will open the second day of events of the two-day symposium, “Stem Cell Policy and Advocacy Summit: Sustaining the Mandate for Cures,” to be held June 11 and 12 in Houston at Baylor College of Medicine. Besides serving as associate director at IBT, Dr. Schwartz leads IBT’s newly established Center for Molecular Development and Diseases. IBT is located in the famed Texas Medical Center in Houston and is a part of the A&M Health Science Center, which is a sponsor of the symposium.
During his 30-year research career, Dr. Schwartz became widely recognized for his research on the developmental and genetic aspects of congenital heart disease. Currently he is engaged in a transatlantic effort that studies how to help damaged hearts repair themselves using stem cells from adult heart tissue. This research is supported by a $6 million, five-year grant from Fondation Leduq, based in Paris, France, and Dr. Schwartz’s work is one of five senior scientists covered by this grant.
“Our stem cell research will benefit present and future heart disease sufferers,” explains Dr. Schwartz, “plus those who have been and will be afflicted by various forms of cancer. I am excited by the opportunities we have before us.”
Bernard Siegel, J.D., organizer of the stem cell summit and founder and executive director of the Genetics Policy Institute, says, “The participation of the Institute of Biosciences and Technology and of The Texas A&M University System Health Science Center shows that these fine institutions recognize the importance of stem cell research to the future of humankind. Dr. Schwartz will represent the many Texas A&M scientists who are working hard to make advances in regenerative medicine.” The Genetics Policy Institute is the leading non-profit organization dedicated to preventing human reproductive cloning while advocating the responsible use of therapeutic cloning research.
The Texas A&M University System Health Science Center provides the state with health education, outreach and research. Its five components located in communities throughout Texas are Baylor College of Dentistry, the College of Medicine, the Graduate School of Biomedical Sciences, the Institute of Biosciences and Technology and the School of Rural Public Health.
– 30 –

— Marketing & Communications